Medical Equipment

Implantable Remote Patient Monitoring Devices Market Size Forecast: Revenue and CAGR by 2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Implantable Remote Patient Monitoring Devices Industry By The Forecast Year 2029?

The implantable remote patient monitoring devices market size has experienced exponential growth in recent years. It is anticipated to expand from $8.39 billion in 2024 to $10.26 billion in 2025, achieving a compound annual growth rate (CAGR) of 22.2%. The past growth can be attributed to several factors: the increasing prevalence of chronic and cardiovascular diseases, a rising demand for early diagnosis and continuous monitoring, a growing aging population requiring long-term care, an increasing shift toward home-based healthcare, and rising healthcare costs that encourage preventive monitoring.

The implantable remote patient monitoring devices market size is projected to experience substantial growth in the upcoming years, reaching $22.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 21.8%. The expansion during the forecast period can be attributed to increased government backing and reimbursement coverage, rising awareness concerning personalized and precision medicine, growing investments in digital health and MedTech startups, and an increase in post-surgical complications and rehospitalizations. Significant trends anticipated in this period include advancements in miniaturization and biocompatible materials, the integration of artificial intelligence (AI) and machine learning for predictive analytics, technology convergence with 5G and Internet of Things (IoT) networks, developments in battery-free and energy-harvesting implants, and enhancements in cybersecurity protocols for medical implants.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27316&type=smp

Which Drivers Are Impacting The Implantable Remote Patient Monitoring Devices Market?

The future expansion of the implantable remote patient monitoring devices market is anticipated to be significantly boosted by the rising uptake of telehealth services. Telehealth services encompass healthcare delivery from a distance, leveraging tools like phones, video conferencing, or applications, enabling patients to seek medical advice without physical clinic or hospital visits. This increase in telehealth service utilization stems from a rising need for ongoing and immediate health tracking for individuals with long-term illnesses, facilitating prompt medical actions while reducing the necessity for repeated hospital trips. Telehealth functionalities augment implantable remote patient monitoring devices through real-time data exchange between patients and medical professionals, thereby aiding quick medical judgments and lessening the requirement for physical consultations. These services enhance the management of chronic diseases by providing continuous oversight and early intervention, which in turn boosts healthcare efficiency and patient convenience. A notable example is data from May 2024 by the Australian Digital Health Agency, an Australia-based government organization, which reported that between March 2020 and July 2022, more than 95,000 practitioners delivered 118.2 million telehealth services to 18 million patients. Consequently, the expanding use of telehealth services is a significant catalyst for the growth of the implantable remote patient monitoring devices market.

What Are The Emerging Segments Gaining Attention In The Implantable Remote Patient Monitoring Devices Market?

The implantable remote patient monitoring devices market covered in this report is segmented

1) By Product: Blood Glucose Monitoring Systems, Cardiac Monitoring Devices, Weight Monitoring Devices, Other Products

2) By Application: Cardiovascular Diseases, Neurological Disorders, Diabetes, Other Applications

3) By End User: Hospital, Ambulatory Surgery Centers, Home Care Settings, Other End Users

Subsegments:

1) By Blood Glucose Monitoring Systems: Continuous Glucose Monitoring (CGM) Devices, Self-Monitoring Blood Glucose (SMBG) Devices, Lancets And Lancing Devices, Glucose Test Strips, Blood Glucose Meters,

2) By Cardiac Monitoring Devices: Electrocardiogram (ECG) Devices, Implantable Loop Recorders, Holter Monitors, Event Monitors, Mobile Cardiac Telemetry Devices,

3) By Weight Monitoring Devices: Digital Weighing Scales, Smart Body Composition Monitors, Infant Scales, Chair Scales, Bed Scales,

4) By Other Products: Respiratory Monitoring Devices, Multiparameter Monitors, Fetal And Neonatal Monitoring Devices, Temperature Monitoring Devices, Neuromonitoring Devices

How Are Trends Influencing The Implantable Remote Patient Monitoring Devices Market?

Leading companies in the implantable remote patient monitoring devices market are concentrating on creating advanced products, such as implantable cardiac monitors, to boost the accuracy of monitoring for cardiac arrhythmias. An implantable cardiac monitor (ICM), also known as an implantable loop recorder (ILR), is a compact device placed just under the skin, typically on the left side of the chest, designed to continuously track and record the heart’s electrical activity over an extended duration. For example, in June 2023, Biotronik AG, a Switzerland-based medical technology company, launched its BIOMONITOR IV implantable cardiac monitor. This cutting-edge ICM combines BIOTRONIK’s SmartECG technology with artificial intelligence to decrease all false positive detections by 86% while maintaining 98% of true episodes. This monitor also has the ability to distinguish between premature atrial contractions (PACs) and premature ventricular contractions (PVCs), providing healthcare professionals with enhanced tools for risk stratification and diagnosis.

Who Are The Major Companies Operating In The Implantable Remote Patient Monitoring Devices Market?

Major companies operating in the implantable remote patient monitoring devices market are Abbott Laboratories, Honeywell Life Sciences, Medtronic plc, Siemens Healthineers, Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Dexcom Inc., Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova PLC, MicroPort Scientific Corporation, iRhythm Technologies Inc., NeuroPace Inc., Profusa Inc., Senseonics Holdings Inc., Xeltis AG, GlySens Inc., Kenzen Inc., Qura Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/implantable-remote-patient-monitoring-devices-global-market-report

Which Regional Markets Are Contributing Most To The Implantable Remote Patient Monitoring Devices Industry Expansion?

North America was the largest region in the implantable remote patient monitoring devices market in 2024. The regions covered in the implantable remote patient monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Implantable Remote Patient Monitoring Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27316&type=smp

Browse Through More Reports Similar to the Global Implantable Remote Patient Monitoring Devices Market 2025, By The Business Research Company

Automotive Usage Based Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automotive-usage-based-insurance-global-market-report

Motor Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/motor-insurance-global-market-report

Car Insurance Aggregators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/car-insurance-aggregators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795